MedPath

effect of Agomelatin on the migraine

Phase 3
Conditions
Migraine.
Migraine without aura [common migraine]
G43.0
Registration Number
IRCT20230303057599N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Migraine without aura without the use of preventive medicine

Exclusion Criteria

Pregnant woman
those taking certain medications

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity and number of headache attacks. Timepoint: Three months after the intervention. Method of measurement: Checklist and interview.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath